The best portable generators and power stations offer a practical backup for outages big and small, keeping critical devices ...

(Alliance News) - PureTech Health PLC on Monday said its idiopathic pulmonary fibrosis drug candidate deupirfenidone has cleared a key regulatory milestone, with the US Food & Drug Administration ...

- Phase 3 study population expanded to include adults over 65 years of age in addition to subjects with high-risk co-morbidities and immune compromised status SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE ...

- Participants will include adults over 65 years of age in addition to individuals with high-risk co-morbidities and immune compromised status SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Cidara ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...

Pegozafermin is ETNB’s long-acting FGF21 analog. It’s undergoing three Phase 3 trials. Two of those late-stage trials are for MASH (F2-F4), and the third is for severe hypertriglyceridemia. Also, ETNB ...

The biggest stories of the day delivered to your inbox.

Abstract: The dual-winding induction generator power system, as a device capable of integrated ac–dc generation, plays a crucial role in the stability of the power generation system and the quality of ...

Abstract: Wound rotor synchronous starter/generator (WRSSG) faces challenges in excitation during the starting mode. The existing single-phase AC excitation method, though simple to implement, suffers ...

1 Electric Power Research Institute of Guizhou Power Grid Co. Ltd., Guiyang, China 2 XJ Electric Co. Ltd., Xuchang, China In this paper, A coordinated power quality improvement control strategy for ...